[HTML][HTML] Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
… Among cancer mortality rates, lung cancer mortality is estimated to be the … Non-small cell
lung cancer (NSCLC) is the most common epithelial lung cancer over small cell lung cancer (…
lung cancer (NSCLC) is the most common epithelial lung cancer over small cell lung cancer (…
Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment
N Duma, R Santana-Davila, JR Molina - Mayo Clinic Proceedings, 2019 - Elsevier
… of non–small cell lung cancer (NSCLC). Screening has been introduced with the goal of
early detection. The National Lung Screening Trial found a lung cancer mortality benefit of 20% …
early detection. The National Lung Screening Trial found a lung cancer mortality benefit of 20% …
Natural history of stage I non-small cell lung cancer: implications for early detection
… Concern has been raised that early detection of lung cancer may lead to the treatment of
clinically … in patients with untreated stage I non-small cell lung cancer (NSCLC) is uncommon. …
clinically … in patients with untreated stage I non-small cell lung cancer (NSCLC) is uncommon. …
Non-small-cell lung cancer
… In the decade since the last Lancet Seminar on lung cancer … , diagnosis, and treatment
of non-small-cell lung cancer (… cells, blood, sputum, breath, and urine for early diagnosis or …
of non-small-cell lung cancer (… cells, blood, sputum, breath, and urine for early diagnosis or …
Non-small-cell lung cancer
C Gridelli, A Rossi, DP Carbone, J Guarize… - Nature reviews Disease …, 2015 - nature.com
… Regardless, brain imaging should be performed in patients with early-stage lung cancer …
benefits before lung cancer development, smoking cessation after diagnosis increases survival …
benefits before lung cancer development, smoking cessation after diagnosis increases survival …
The biology and management of non-small cell lung cancer
RS Herbst, D Morgensztern, C Boshoff - Nature, 2018 - nature.com
… Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been
… of tumour progression, and advancing early detection and multimodal care. The use of small …
… of tumour progression, and advancing early detection and multimodal care. The use of small …
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
Y Tang, G Qiao, E Xu, Y Xuan, M Liao… - OncoTargets and …, 2017 - Taylor & Francis
… Despite the progress made in the treatment of non-small cell lung cancer (NSCLC) over
the … because of initial diagnosis at a late stage. Currently, its detection primarily relies on …
the … because of initial diagnosis at a late stage. Currently, its detection primarily relies on …
Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies
L Chang, J Li, R Zhang - … et Biophysica Acta (BBA)-Reviews on Cancer, 2022 - Elsevier
… As reported by Siegel et al., the cancer mortality rate has continued to … of lung cancer,
especially non-small cell lung cancer (NSCLC), owing to less smoking. It is expected that cancer …
especially non-small cell lung cancer (NSCLC), owing to less smoking. It is expected that cancer …
[HTML][HTML] miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)
Y Han, H Li - Journal of thoracic disease, 2018 - ncbi.nlm.nih.gov
… Approximately 85% of lung cancers are classified as non-small cell lung cancer (NSCLC),
a less aggressive form of tumor than small cell lung cancer (the remaining 15% of all lung …
a less aggressive form of tumor than small cell lung cancer (the remaining 15% of all lung …
[HTML][HTML] 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard… - Annals of …, 2014 - Elsevier
… on Lung Cancer was held … non-small-cell lung cancer (NSCLC) in each of four areas:
pathology and molecular biomarkers, first-line/second and further lines in advanced disease, early-…
pathology and molecular biomarkers, first-line/second and further lines in advanced disease, early-…